Teva unloads plant, U.S. OTC line to PL Developments | Fierce Pharma
Teva Pharmaceuticals to Buy Allergan's Generics Business - The New York Times
Teva recalls US-made drugs following contamination fears - The Boston Globe
California bill would fight deals that delay generic drugs | Fierce Healthcare
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Teva pharmaceuticals hi-res stock photography and images - Alamy
Teva's recall of U.S.-made drugs latest example of contamination fears in generic marketplace; report says Lilly, Pfizer and former Mylan plant in Morgantown have been cited in the past | WV News
Teva Pharmaceuticals: Making Quality Health Care Accessible
Teva unifies pharmaceutical packaging worldwide | packagingdigest.com
Teva Pharmaceutical Stock: Gem Among Generic Pharma Companies (NYSE:TEVA) | Seeking Alpha
Generic-drug maker Teva steals market share from Big Pharma - Aug. 5, 2009
Teva Pays $420 Million to End Generic-Drug Securities Suit (1)
Teva Pharmaceuticals - Wikipedia
Teva's $300 generic EpiPen now available in limited doses - Philadelphia Business Journal
Teva Pharmaceuticals
Anything but Generic: A map for Selling to Teva Pharmaceuticals
Teva unloads plant, U.S. OTC line to PL Developments | Fierce Pharma
Teva completes $40b purchase of Allergan generics arm | The Times of Israel
Teva Pharmaceuticals: Making Quality Health Care Accessible
Teva Pharmaceuticals - Wikipedia
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State Prosecutors Say - The New York Times
Teva, one of the biggest generic makers, joins the the brand-name club
Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion Across Major Markets, According to Independent Analysis | Business Wire
Look out, Teva: Mylan's Copaxone copy has already captured serious share | Fierce Pharma
